147 related articles for article (PubMed ID: 15557835)
1. Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm.
Segal E; Greenlee JD; Hata SJ; Perel A
J Neurosurg Anesthesiol; 2004 Oct; 16(4):296-8. PubMed ID: 15557835
[TBL] [Abstract][Full Text] [Related]
2. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
3. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
4. Cardiac performance enhancement and hypervolemic therapy.
Levy ML; Day JD; Zelman V; Giannotta SL
Neurosurg Clin N Am; 1994 Oct; 5(4):725-39. PubMed ID: 7827481
[TBL] [Abstract][Full Text] [Related]
5. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.
Krayenbühl N; Hegner T; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():247-50. PubMed ID: 11563298
[No Abstract] [Full Text] [Related]
6. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
7. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.
Awad IA; Carter LP; Spetzler RF; Medina M; Williams FC
Stroke; 1987; 18(2):365-72. PubMed ID: 3564092
[TBL] [Abstract][Full Text] [Related]
8. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
Hoh BL; Carter BS; Ogilvy CS
Neurosurgery; 2002 Jun; 50(6):1207-11; discussion 1211-2. PubMed ID: 12015837
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
10. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage.
Muehlschlegel S; Dunser MW; Gabrielli A; Wenzel V; Layon AJ
Neurocrit Care; 2007; 6(1):3-10. PubMed ID: 17356185
[TBL] [Abstract][Full Text] [Related]
11. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].
Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA
Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430
[TBL] [Abstract][Full Text] [Related]
12. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.
Mori T; Katayama Y; Kawamata T; Hirayama T
J Neurosurg; 1999 Dec; 91(6):947-52. PubMed ID: 10584839
[TBL] [Abstract][Full Text] [Related]
13. The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective.
Chittiboina P; Conrad S; McCarthy P; Nanda A; Guthikonda B
World Neurosurg; 2011; 75(5-6):660-4. PubMed ID: 21704933
[TBL] [Abstract][Full Text] [Related]
14. Ruptured Mycotic Aneurysm and Cerebral Vasospasm in the Setting of Endocarditis and Heart Failure Requiring Cardiothoracic Surgery: Case Report and Literature Review.
Lin CT; Tranmer B; Durham S; Johnson D; Hamlin M; Bolman RM
World Neurosurg; 2017 Apr; 100():711.e13-711.e18. PubMed ID: 28153625
[TBL] [Abstract][Full Text] [Related]
15. Which H is the most important in triple-H therapy for cerebral vasospasm?
Treggiari MM; Deem S
Curr Opin Crit Care; 2009 Apr; 15(2):83-6. PubMed ID: 19276798
[TBL] [Abstract][Full Text] [Related]
16. Impact of clipping versus coiling on postoperative hemodynamics and pulmonary edema after subarachnoid hemorrhage.
Horie N; Iwaasa M; Isotani E; Ishizaka S; Inoue T; Nagata I
Biomed Res Int; 2014; 2014():807064. PubMed ID: 24818154
[TBL] [Abstract][Full Text] [Related]
17. Postoperative hypertensive-hypervolaemic-haemodilution (Triple H) therapy in the treatment of vasospasm following aneurysmal subarachnoid haemorrhage.
Gupta D; Sharma BS; Gupta SK; Bapuraj R; Khosla VK
Neurol India; 2000 Jun; 48(2):126-31. PubMed ID: 10878775
[TBL] [Abstract][Full Text] [Related]
18. The present role of "triple-H" therapy in the management of cerebral vasospasm.
Findlay JM
World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
[No Abstract] [Full Text] [Related]
19. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage.
Mutoh T; Kazumata K; Ishikawa T; Terasaka S
Stroke; 2009 Jul; 40(7):2368-74. PubMed ID: 19461028
[TBL] [Abstract][Full Text] [Related]
20. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Sakowitz OW; Unterberg AW
Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
